A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)
Status:
Terminated
Trial end date:
2018-10-02
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and tolerability, the pharmacokinetics and
the efficacy of radiprodil in abolishing clinical spasms in subjects with drug-resistant
infantile spasms